ArticleCells2024

Dual Targeting of Glioblastoma Cells with Bispecific Killer Cell Engagers Directed to EGFR and ErbB2 (HER2) Facilitates Effective Elimination by NKG2D-CAR-Engineered NK Cells.

Anne Kiefer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.